Yes, we coordinate comprehensive extractables and leachables (E&L) testing supporting FDA and international regulatory submissions for drug-device combination products. Working with certified analytical laboratories, we facilitate ISO 10993-12 sample preparation and extraction studies, ISO 10993-18 chemical characterization using GC-MS, LC-MS, and ICP-MS, and controlled extraction studies simulating worst-case drug contact conditions (temperature, duration, solvent systems). We provide material specifications and processing documentation required for E&L study design. Our quality system maintains material lot traceability linking components to specific E&L testing batches. This comprehensive approach supports safety assessments per FDA guidance on container-closure systems and satisfies regulatory requirements for pharmaceutical device combination products.